Cargando…

Editorial: Nuclear Medicine in the Context of Personalized Medicine

Detalles Bibliográficos
Autores principales:	Barbet, Jacques, Bernaudin, Myriam, Payoux, Pierre, Cicone, Francesco, Gaugler, Marie-Hélène, Kraeber-Bodéré, Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296094/ https://www.ncbi.nlm.nih.gov/pubmed/32582736 http://dx.doi.org/10.3389/fmed.2020.00252

Ejemplares similares

Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2014)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

Pretargeting for imaging and therapy in oncological nuclear medicine
por: Bailly, Clément, et al.
Publicado: (2017)

Editorial: “Nuclear medicine in cancer diagnosis”
por: Cicone, Francesco, et al.
Publicado: (2022)

Highlights lecture EANM 2016: “Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine”
por: Aboagye, Eric O., et al.
Publicado: (2017)

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
por: Bailly, Clément, et al.
Publicado: (2019)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

Risk Management Through an “Activity Contradictions” Lens: Exposure to Low Doses of Radiation in Nuclear Medicine
por: Lonceint, Romain, et al.
Publicado: (2019)

Cell Tracking in Cancer Immunotherapy
por: Perrin, Justine, et al.
Publicado: (2020)

Editorial: Reviews in: Radiopharmaceuticals in nuclear medicine
por: Lau, Chuen-Yen, et al.
Publicado: (2023)

Editorial: Insights in nuclear medicine: 2022
por: Treglia, Giorgio
Publicado: (2023)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

[(18)F]-Fludarabine for Hematological Malignancies
por: Barré, Louisa, et al.
Publicado: (2019)

Editorial: Personalized medicine and infectious disease management
por: Haddad-Boubaker, Sondes, et al.
Publicado: (2023)

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
por: Bodet-Milin, Caroline, et al.
Publicado: (2019)

Quantitative Evaluation of Therapeutic Response by FDG-PET–CT in Metastatic Breast Cancer
por: Goulon, Dorothée, et al.
Publicado: (2016)

Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosis
por: Treglia, Giorgio, et al.
Publicado: (2023)

Editorial: Global excellence in nuclear medicine: North America
por: Jha, Abhishek, et al.
Publicado: (2023)

Editorial: Radiomics and artificial intelligence in radiology and nuclear medicine
por: Annunziata, Salvatore, et al.
Publicado: (2023)

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
por: Bodet-Milin, Caroline, et al.
Publicado: (2015)

Editorial: Perspectives in Small Animal Radionuclide Imaging
por: Cicone, Francesco, et al.
Publicado: (2020)

Prognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy
por: Bailly, Clément, et al.
Publicado: (2014)

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)

Immuno-PET: Design options and clinical proof-of-concept
por: Lugat, Alexandre, et al.
Publicado: (2022)

Editorial: MEDICIS-promed: Advances in radioactive ion beams for nuclear medicine
por: Stora, Thierry, et al.
Publicado: (2022)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging
por: Colombié, Mathilde, et al.
Publicado: (2015)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
por: Bailly, Clément, et al.
Publicado: (2019)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Personalized medicine and education: the challenge
por: Haiech, Jacques, et al.
Publicado: (2012)

Editorial: Medicine and Society
por: Ghezzi, Pietro, et al.
Publicado: (2020)

Editorial: Pruritus Medicine
por: Ständer, Sonja, et al.
Publicado: (2021)

Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
por: Carlier, Thomas, et al.
Publicado: (2013)

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials
por: Bailly, Clément, et al.
Publicado: (2016)

Editorial: Systemic involvement in obstructive sleep apnea: Personalized medicine to improve health outcomes
por: Labarca, Gonzalo, et al.
Publicado: (2022)

Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification
por: Marasco, Emiliano, et al.
Publicado: (2022)

Editorial: Personalized medicine—Where do we stand regarding bench to bedside translation?
por: Raghavendran, Hanumantha Rao Balaji, et al.
Publicado: (2023)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

Editorial: Transfusion Medicine and Blood
por: Prudent, Michel, et al.
Publicado: (2019)

Editorial: Trends in Digital Medicine
por: Capobianco, Enrico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ts4mi433jrko44ssfh0tbffr3p